Rebecca Sardell
MRes, PhD
Medical Statistician
Rebecca Sardell is a Medical Statistician in the Renal Studies Group within the Clinical Trial Service Unit & Epidemiological Studies Unit (CTSU).
Rebecca has a degree in Biological Sciences from the University of Oxford, an MRes in Ecology and Environmental Management from the University of York, and a PhD in Biological Sciences from the University of Aberdeen.
After completing her PhD in 2011, she held a postdoctoral position in evolutionary biology at Florida State University. Following this she completed an NIH-funded postdoctoral training program in genetic epidemiology at the Hussman Institute for Human Genomics at the University of Miami, where she focused on the genomics of age-related macular degeneration.
Before joining the CTSU in 2020 she spent 3 years as an epidemiologist/research specialist at the Texas Cancer Registry.
Recent publications
-
Empagliflozin lowers serum uric acid in chronic kidney disease: exploratory analyses from the EMPA-KIDNEY trial.
Journal article
Mayne KJ. et al, (2024), Nephrol Dial Transplant
-
Frailty, multimorbidity and polypharmacy: exploratory analyses of the effects of empagliflozin from the EMPA-KIDNEY trial.
Journal article
Mayne KJ. et al, (2024), Clin J Am Soc Nephrol, 19, 1119 - 1129
-
Texas Has the Highest Hepatocellular Carcinoma Incidence Rates in the USA
Journal article
El-Serag HB. et al, (2020), Dig Dis Sci
-
AMISH EYE STUDY: Baseline Spectral Domain Optical Coherence Tomography Characteristics of Age-Related Macular Degeneration
Journal article
Nittala MG. et al, (2019), Retina, 39, 1540 - 1550
-
A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants
Journal article
Fritsche LG. et al, (2016), Nat Genet, 48, 134 - 143